Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo

Stacy L. Moulder, F. Michael Yakes, Roberto Bianco, Carlos L. Arteaga, Carlos L. Arteaga, Jean F. Simpson, Carlos L. Arteaga, Senthil K. Muthuswamy

Research output: Contribution to journalArticlepeer-review

518 Scopus citations

Fingerprint

Dive into the research topics of 'Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences